Ondine Biomedical, Inc. (OBIMF)
0.14
0.00 (0.00%)
USD |
OTCM |
Nov 18, 16:00
Ondine Biomedical Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 09, 2026 | 80.31M |
| November 06, 2026 | 80.31M |
| November 05, 2026 | 125.21M |
| November 04, 2026 | 125.21M |
| November 03, 2026 | 125.21M |
| November 02, 2026 | 125.21M |
| October 30, 2026 | 125.21M |
| October 29, 2026 | 125.21M |
| October 28, 2026 | 125.21M |
| October 27, 2026 | 125.21M |
| October 26, 2026 | 125.21M |
| October 23, 2026 | 125.21M |
| October 22, 2026 | 125.21M |
| October 21, 2026 | 125.21M |
| October 20, 2026 | 125.21M |
| October 19, 2026 | 125.21M |
| October 16, 2026 | 125.21M |
| October 15, 2026 | 125.21M |
| October 14, 2026 | 125.21M |
| October 13, 2026 | 125.21M |
| October 12, 2026 | 125.21M |
| October 09, 2026 | 125.21M |
| October 08, 2026 | 125.21M |
| October 07, 2026 | 125.21M |
| October 06, 2026 | 125.21M |
| Date | Value |
|---|---|
| October 05, 2026 | 125.21M |
| October 02, 2026 | 125.21M |
| October 01, 2026 | 125.21M |
| September 30, 2026 | 125.21M |
| September 29, 2026 | 125.21M |
| September 28, 2026 | 125.21M |
| September 25, 2026 | 125.21M |
| September 24, 2026 | 125.21M |
| September 23, 2026 | 125.21M |
| September 22, 2026 | 125.21M |
| September 21, 2026 | 142.04M |
| September 18, 2026 | 142.04M |
| September 17, 2026 | 142.04M |
| September 16, 2026 | 142.04M |
| September 15, 2026 | 142.04M |
| September 14, 2026 | 142.04M |
| September 11, 2026 | 142.04M |
| September 10, 2026 | 142.04M |
| September 09, 2026 | 142.04M |
| September 08, 2026 | 142.04M |
| September 04, 2026 | 142.04M |
| September 03, 2026 | 142.04M |
| September 02, 2026 | 142.04M |
| September 01, 2026 | 142.04M |
| August 31, 2026 | 142.04M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Edesa Biotech, Inc. | 17.92M |
| Co-Diagnostics, Inc. | 2.291M |
| ProMIS Neurosciences, Inc. | -16.03M |
| Numinus Wellness, Inc. | 4.917M |
| Alpha Tau Medical Ltd. | 1.019B |
Enterprise Value Related Metrics
| Earnings Yield | -33.64% |
| Normalized Earnings Yield | -33.71 |